China has taken several measures over the past two years to cut red tape for the drug discovery industry and incentivise innovation. Photo: Shutterstock

Fancy biotech stocks? Industry observers warn investors to temper exuberance with caution

Industry executives are upbeat about the prospects of China’s biotech sector, as Beijing has taken a slew of measures to speed up new drug approval and expect pharmaceutical sales to grow by 15pc from 2019 to 2021

Topic |   Pharmaceuticals

TOP PICKS

China has taken several measures over the past two years to cut red tape for the drug discovery industry and incentivise innovation. Photo: Shutterstock
READ FULL ARTICLE